| Section | Status | CDF | Name |
| 08.01.01 | Restricted Use |  |
Bendamustine |
| 08.01.05 | Restricted Use | |
Bevacizumab Avastin® |
| 08.01.05 | Restricted Use | |
Bortezomib Velcade® |
| 08.01.05 | Restricted Use | |
Bosutinib Bosulif® |
| 08.01.05 | Restricted Use | |
Dasatinib Sprycel® |
| 08.01.05 | Restricted Use | |
Ibrutinib Imbruvica® |
| 08.01.05 | Restricted Use | |
Ixazomib Ninralo® |
| 08.01.05 | Restricted Use | |
Larotrectinib 20mg/mL oral solution Vitrakvi® |
| 08.02.04 | Restricted Use | |
Lenalidomide Revlimid® |
| 08.01.05 | Restricted Use | |
Neratinib Nerlynx® |
| 08.01.05 | Restricted Use | |
Osimertinib mesylate Tagrisso® |
| 08.01.05 | Restricted Use | |
Panitumumab infusion Vectibix® |
| 08.01.05 | Restricted Use | |
Pertuzumab Perjeta® |
| 08.01.05 | Restricted Use | |
Ribociclib Kisqali® |
| 08.01.05 | Restricted Use | |
Ruxolitinib Jakavi® |
| 08.01.05 | Restricted Use | |
Venetoclax |